• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prevalence of persistent SARS-CoV-2 in a large community surveillance study - Nature

Mary Wilson

Well-known member
Published 21 February 2024

DOI https://doi.org/10.1038/s41586-024-07029-4

Ghafari, M., Hall, M., Golubchik, T. et al.

Abstract

Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks[SUP]1,2,3,4,5[/SUP], give rise to highly divergent lineages[SUP]6,7,8[/SUP] and contribute to cases with post-acute COVID-19 sequelae (long COVID)[SUP]9,10[/SUP]. However, the population prevalence of persistent infections, their viral load kinetics and evolutionary dynamics over the course of infections remain largely unknown. Here, using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as ‘persistent infections’ as available evidence suggests that they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Individuals with persistent infection had more than 50% higher odds of self-reporting long COVID than individuals with non-persistent infection. We estimate that 0.1–0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, whereas others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies and/or are commonly found in immunocompromised people[SUP]11,12,13,14[/SUP]. This work has profound implications for understanding and characterizing SARS-CoV-2 infection, epidemiology and evolution.

https://www.nature.com/articles/s41586-024-07029-4#citeas

 
Back
Top Bottom